Astec LifeSciences Ltd Q4FY25 consolidated loss reduces QoQ to Rs. 16.08 crores

Astec LifeSciences Limited has reported Consolidated financial results for the period ended March 31, 2025.

Financial Results (Q4 FY2025) - QoQ Comparison

The company has reported total income of Rs. 120.3182 crores during the period ended March 31, 2025 as compared to Rs. 95.7730 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs. -16.0876 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. -40.3811 crores for the period ended December 31, 2024.

The company has reported EPS of Rs. -8.20 for the period ended March 31, 2025 as compared to Rs. -20.59 for the period ended December 31, 2024.

Financials	Q4 FY2025	Q3 FY2025	% Change
Total Income	₹ 120.3182 crs	₹95.7730 crs	25.63%
Net Profit	₹-16.0876 crs	₹-40.3811 crs	60.16%
EPS	₹-8.20	₹-20.59	60.17%

Financial Results (Q4 FY2025) - YoY Comparison

The company has reported total income of Rs. 120.3182 crores during the period ended March 31, 2025 as compared to Rs.155.7955 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs.-16.0876 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.-0.9739 crores for the period ended March 31, 2024.

The company has reported EPS of Rs.-8.20 for the period ended March 31, 2025 as compared to Rs.-0.50 for the period ended March 31, 2024.

Financials	Q4 FY2025	Q4 FY2024	% Change
Total Income	₹ 120.3182 crs	₹155.7955 crs	-22.77%
Net Profit	₹-16.0876 crs	₹-0.9739 crs	1,551.87%
EPS	₹-8.20	₹-0.50	1,540.00%

Financial Results (Year Ended FY2025) - YoY Comparison

The company has reported total income of Rs.386.9322 crores during the Financial Year ended March 31, 2025 as compared to Rs.463.8246 crores during the Financial Year ended March 31, 2024.

The company has posted net profit / (loss) of Rs.-134.7524 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.-46.9295 crores for the Financial Year ended March 31, 2024.

The company has reported EPS of Rs.-68.71 for the Financial Year ended March 31, 2025 as compared to Rs.-23.93 for the Financial Year ended March 31, 2024.

Financials	Year Ended FY2025	Year Ended FY2024	% Change
Total Income	₹386.9322 crs	₹463.8246 crs	-16.58%
Net Profit	₹-134.7524 crs	₹-46.9295 crs	187.14%
EPS	₹-68.71	₹-23.93	187.13%

Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 769.60 as compared to the previous close of Rs. 762.60. The total number of shares traded during the day was 1807 in over 251 trades.

The stock hit an intraday high of Rs. 788.70 and intraday low of 756.55. The net turnover during the day was Rs. 1400562.00.

Source : Equity Bulls

Keywords

AstecLifeSciences Q4FY25 Q4FY2025 FY2025 ResultUpdate